SCHEMBL6565005

SCHEMBL6565005

CCC(NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(O)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 2/20 0.47
KIF11 P52732 1/20 0.41
GRIN1 Q05586 4/20 0.39
GRIN2A Q12879 4/20 0.39
GRIN2D O15399 3/20 0.39
GRIN2C Q14957 3/20 0.39
GRIN2B Q13224 2/20 0.39
CDK4 P11802 4/20 0.37
CCND1 P24385 4/20 0.37
CCNE1 P24864 4/20 0.37
CDK2 P24941 4/20 0.37
CDK7 P50613 4/20 0.37
CCNH P51946 4/20 0.37
CDK1 P06493 3/20 0.37
CCNB1 P14635 3/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TRPA1 O75762 2/20 0.35
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854524 1.00 KCNN4 (0.47) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3852207 1.00 KCNN4 (0.47) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3853261 0.86 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3666885 0.86 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL4484584 0.86 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3307096 0.86 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3853041 0.83 KCNN4 (0.47) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3856263 0.83 KCNN4 (0.47) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3862734 0.83 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D
SCHEMBL3862881 0.83 KCNN4 (0.50) KCNN4KIF11GRIN1GRIN2AGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399446-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2004-03-24 EP disclosed
WO-2003002565-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE N THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2003-01-09 WO disclosed